SECsense Logo

Intelligent Bio Solutions Inc. 8-K Report: Key Insights & Financial Overview

$INBS
Form 8-K
Filed on: 2025-01-06
Source
Intelligent Bio Solutions Inc. 8-K Report: Key Insights & Financial Overview

Here’s a summary of the key information extracted from the provided section of the financial report:

  1. Entity Information:
  • Name: Intelligent Bio Solutions Inc.
  • CIK (Central Index Key): 0001725430
  • SEC File Number: 001-39825
  • IRS Employer Identification Number (EIN): 82-1512711
  • Address: 135 West 41st Street, 5th Floor, New York, NY 10036
  • Contact Number: (646) 828-8258
  1. Report Type:
  • Form: 8-K (Current Report)
  1. Reporting Date:
  • Date of Filing: January 2, 2025
  • Period Covered: January 2, 2025 (indicates a single day reporting)
  1. Stock Information:
  • Security Type: Common Stock
  • Par Value: $0.01
  • Stock Symbol: INBS (listed on NASDAQ)
  1. Currency and Measurement:
  • Currency Unit: USD (U.S. Dollars)
  • Shares Unit: Shares
  1. Key Context:
  • The filing is structured in XBRL format, which allows for the extraction of financial data in a standardized manner.

Analysis and Insights:

  • The report indicates that Intelligent Bio Solutions Inc. is actively filing with the SEC, which is important for transparency and compliance, especially for publicly traded companies.
  • The use of the 8-K form suggests that the company is reporting significant events or corporate changes that shareholders need to be aware of, although the specific content of this filing is not provided.
  • The company is based in New York and listed on NASDAQ, which could reflect a level of credibility and investor interest in the biotech sector, particularly with the ongoing advancements in medical technologies.
  • The mention of the common stock and its par value indicates the company's capital structure and provides insight into its equity financing strategy.

Overall, this section provides foundational information about Intelligent Bio Solutions Inc. and sets the stage for a deeper understanding of its financial health and corporate actions as reported in the 8-K filing.